Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients

IntroductionCurrently there are no biomarkers that are predictive of when patients with type-2 diabetes (T2D) will progress to more serious kidney disease i.e., diabetic nephropathy (DN). Biomarkers that could identify patients at risk of progression would allow earlier, more aggressive treatment in...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Carla Harkin, Diego Cobice, Simon Brockbank, Stephanie Bolton, Frances Johnston, Anna Strzelecka, Joanne Watt, Mary Jo Kurth, John V. Lamont, Peter Fitzgerald, Tara Moore, Mark W. Ruddock
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Frontiers Media S.A. 2022-06-01
سلاسل:	Frontiers in Endocrinology
الموضوعات:	diabetic nephropathy midkine sTNFR1 sTNFR2 L-FABP H-FABP
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fendo.2022.887237/full
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!